TY  - JOUR
PY  - 2020//
TI  - Long-term puberty suppression for a nonbinary teenager
JO  - Pediatrics
A1  - Pang, Ken C.
A1  - Notini, Lauren
A1  - McDougall, Rosalind
A1  - Gillam, Lynn
A1  - Savulescu, Julian
A1  - Wilkinson, Dominic
A1  - Clark, Beth A.
A1  - Olson-Kennedy, Johanna
A1  - Telfer, Michelle M.
A1  - Lantos, John D.
SP  - ePub
EP  - ePub
VL  - ePub
IS  - ePub
N2  - Many transgender and gender-diverse people have a gender identity that does not conform to the binary categories of male or female; they have a nonbinary gender. Some nonbinary individuals are most comfortable with an androgynous gender expression. For those who have not yet fully progressed through puberty, puberty suppression with gonadotrophin-releasing hormone agonists can support an androgynous appearance. Although such treatment is shown to ameliorate the gender dysphoria and serious mental health issues commonly seen in transgender and gender-diverse young people, long-term use of puberty-suppressing medications carries physical health risks and raises various ethical dilemmas. In this Ethics Rounds, we analyze a case that raised issues about prolonged pubertal suppression for a patient with a nonbinary gender.<br><br>Copyright © 2020 by the American Academy of Pediatrics.<p />  <p>Language: en</p>
LA  - en
SN  - 0031-4005
UR  - http://dx.doi.org/10.1542/peds.2019-1606
ID  - ref1
ER  -